Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% ...

As her memory faded from Alzheimer’s disease in her late 50s, Tammy Maida began to lose track of her life. Car keys, ...

Daily doses of obicetrapib over 52 weeks led to significant reductions in plasma p-tau217 and other Alzheimer’s disease ...

The first clinical guidelines on the use of blood biomarker tests could help clinicians choose the most appropriate test to ...

A hit Bollywood film sparks public curiosity about early-onset Alzheimer’s — experts break down its causes, symptoms, and how ...

A new study shows that the way amyloid proteins—implicated in Alzheimer's disease—assemble into fibrils can be significantly ...

Data from Most Deeply Characterized Cohort Across Alzheimer's Disease Released by Global Alzheimer’s Platform Foundation and Alzheimer’s Disease Data Initiative ...

A computer program predicts with more than 75% accuracy who will develop dementia in the near future.

New research involving nearly 93,000 adults reveals that following a Mediterranean-style eating pattern significantly reduces ...

New research results reported at the Alzheimer's Association International Conference® 2025 (AAIC®) advanced scientific understanding of risk, diagnosis and treatment of Alzheimer's disease and other ...

TORONTO -- Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to ...